Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Everyone complains that trul is stuck in 1 state, but when they go to expand, they need to spend and raise money...it will pay for itself quickly. This is one of the few pot companies that is doing it correctly...every quarter. Love this company. Only wish it could be uplisted so the big money could pour in.
Nice call. I doubted you when you first called it! Figured it would sell off after ER like usual, looking so strong this time. I didnt sell a single share this time and not selling any.
decent volume today on a green day with no news. glad this is hanging tough.
bullish stock movement here, no?. these otc pot stocks usually sell off after earnings unless blowout. i was expecting a bigger dip and to see this bounce right back, is calming to see. Im holding all my shares and sleeping good at night, actually added a whopping 50 shares at 26.1.
Market cap of a tad over 50 million....on track to have 2020 revenues of a tad under 50 million....and expanding big. What gives?
Better than expected. Im satisfied.
I've trimmed more than half of my position over the past 6 weeks. Anticipating a big dip tomorrow and i'll add it all back. If not, oh well, another missed opportunity on my part.
During June. They haven’t announce which day.
Honestly scaring me with the non disclosure and delay. I’m expecting a bad quarter but then only blue skies ahead.
too much uncertainty with the upcoming ER to breakout until after it is released. IMO
Me too, better value, more current risk, more reward. But eventually would like to be closer to 50/50 in them both.
While i do believe this SP will dip once ER comes out sometime this month, i also believe the future of this company is extremely bright. I have been selling in May...and holding a position long and I will surely be loading up if it dips.
Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement
BY PR Newswire
— 10:41 AM ET 06/02/2020
TORONTO, June 2, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(FRA:TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it is today beginning production of its instant release tablets and has already entered into its first purchase agreement with MediPharm Labs ( MEDIF
Loading...
Loading...
) ("MediPharm") (OTCQX: MEDIF)(Deutsche Borse: MLZ), a global leader in pharma quality cannabinoid based products.
Canntab received its first order under the agreement today, and the value of the full agreement will exceed $1 million. Orders under the agreement will be composed of a mix of Canntab's proprietary instant release tablets delivering THC, CBD and a combination of THC/CBD in 12 different strengths. MediPharm ( MEDIF
Loading...
Loading...
) will purchase and distribute cannabis products on a non-exclusive basis across Canada, through licensed provincial dispensaries.
The exact value of shipments under the agreement will be determined no later than June 30, 2020 and will depend on the final concentrations of Canntab's instant release tablets chosen by MediPharm ( MEDIF ).
Canntab has already filed its 60 day notice for approval to sell this line of products with Health Canada and expects that its tablets will be available for sale in the early summer. Canntab is currently the only company in Canada capable of delivering THC, CBD and/or any combination THC/CBD in pharmaceutical grade tablets or hard pills.
Jeff Renwick, CEO of Canntab said "we are very excited and pleased to have achieved this major milestone in our short history as a company. We are especially pleased to have accomplished this major milestone in the face of the Covid-19 Pandemic which has caused major uncertainty and disruption in world markets, including, Canada. Canntab has continued to work diligently to build shareholder value during this crisis as we are designated an essential business. Signing our first purchase order with a quality partner having a global reach such as MediPharm ( MEDIF
Loading...
Loading...
) is simply the tip of the iceberg for Canntab.".
"We're pleased to be working with Canntab who are leading the way in manufacturing innovative cannabis based tablets," said Pat McCutcheon, Chief Executive Officer, MediPharm ( MEDIF
Loading...
Loading...
). "With MediPharm ( MEDIF
Loading...
Loading...
)'s robust supply chain and established distribution channels, we are excited to roll out novel high quality tablet products in the coming months to medical and adult-use consumers across Canada."
Canntab has filed 13 patents in Canada and United States that cover a range of processes and formulations that it uses to create its precision oral delivery hard tablets, the future of medical cannabis. These patents include Canntab's proprietary nano-emulsification technology, granulation process, methods of manufacturing, and covers its full line of precision oral delivery hard tablets including; Instant (Immediate) Release Tablets, Extended Release Tablets, Oral Dissolvable Tablets and Bi-Layered (Modified Release) Tablets. Canntab has also filed a patent for an exclusive formulation of THC and CBD for the treatment of opioid addiction treatment therapy.
About Canntab Therapeutics ( CTABF
Loading...
Loading...
)
Canntab Therapeutics ( CTABF
Loading...
Loading...
) is a Canadian biopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. Canntab's proprietary hard pill cannabinoid formulations provide doctors, patients and consumers with medical grade solutions which incorporate all the features one would expect from any prescription or over the counter medication sold in Canadian pharmacies. These will include the following formulations: once a day and extended release, both providing an accurate dose and improved shelf stability. The future of medical cannabinoid solutions.
Canntab holds a Cannabis Standard Processing & Sales for Medical Purposes Licence, a Cannabis Research Licence, and an Industrial Hemp Licence from Health Canada.
Additionally, Canntab through its wholly owned American subsidiary is in the process of establishing a CBD manufacturing and distribution business in Florida, USA.
Canntab trades on the Canadian Securities Exchange under the symbol PILL, on the OTCQB under the symbol CTABF, and on the Frankfurt Stock Exchange under the symbol TBF1.
Cautionary Statements
Would be nice to see an update on hexo debt. Looks like they have plenty of cash to pay right now with their recent cash raise. Would make a huge difference in our share price seeing that is the reason we started dropping. Anyone know how to research where it is in court?
I think once we get back to us$2, we’ll quickly rise back to us$3’s.
It seems to be the unlock and dumping since 3/31. Once mr dumper is exhausted and we get through this potential bad quarter Er...should be smooth sailing back up. Global expansion underway.
Cant confirm it for sure, but the Cron double inflating revs was before 4th quarter and before the audited financials...so IMO this accounting error, if there even was any with Medif, shouldve been addressed and fixed prior to that, so i have a very hard time believing that that portion of this rumor is real...but pretty big and quick drop for a rumor, so who knows.
thanks. well, im a sucker and keep buying.
Level 2'rs...is this the same guy dumping today?
Eventually he'll stop or run out and all shares/warrants will be unlocked/exercised and we'll be in good shape. Share price has been pretty stable lately considering everything going on, so its not effecting us too much.
A nice ER would help speed it up, but im thinking this one will be average/decent, but after that will be golden.
I've been buying again this past week, cant help it.
1st q er released 5/10/19 last year. anyone have worries that they havent even announced yet this year, or do you just assume that they are busier from expansion and behind the ball a bit due to covid?
not with this share price.
Aphria just announced their subsidiary recieved EU GMP. So there's hope for us getting it earlier than some may expect.
any word on ER date? I thought i read the 5th on fb investor page, but never saw any confirmation elsewhere.
REPORT: According to a new report by Prohibition Partners, the #medicalcannabis market in Australia, New Zealand and the surrounding islands will account for approximately 40% of the region’s total #cannabis market by 2024: https://bit. ly/2XvJe1l
from medipharm's facebook page
Huge sale on the gummies. I just stocked up and i usually dont use them, but at that price....yes.
C'mon, he predicted the corona virus and knew Hexo was going to try and stiff us. That's talent.
Actually Hippd, i do give you credit for calling its decline to $3, but the rest was pure unpredictable crap luck.
Wow, what a week of news and price action. Cant wait for monday!
Im with you Dude. I have way more shares than I planned to have, i'm slapping my hand when I go to buy more at these bargain prices...just because of the large % of my total portfolio invested in 1 stock. Though I have full confidence in it...I was just early to the party. Actually not early to the party, just too many negatives happened over the past few months.
What's going to happen if we show over 50million sales for 4th q and an increasing profit? What happens when global expansion and 2.0 revenues are added to that? What happens when Hexo pays up and we see they are not needed as a customer. What happens when the coronavirus fears realize that its just a panic to a bad common cold. Pretty obvious that the government is going to do anything possible from letting a recession happen anytime soon. What happens when Nasdaq approves us? Under 200m market cap...hahaha.
2020 revenues on track to exceed current market cap.....hmmmm. Just not right.
I wasn’t referring to you...I commend your honesty.
This one could take awhile to rebound big imo.
Wow, you’re sure singing a different tune than you were.
Nice buy!
looks like the quarterly post-ER shift of money from valens to medif has begun.
Speaking of Valens....ER Monday...should keep this train moving forward.
I can attest Funman is not short. He keeps it real without being too bullish and contributes more than any poster. I've been here for at least 9 months and he's never given me reason to believe anything but.
And even if he is, let him. This is a very peaceful board without any annoying bashers. You cant sing rainbow and butterflys all the time, Id rather keep it real...just like this company.
i'm betting CS had a tip about shoppers drug mart before us.
soon we'll be looking back at this hexo fiasco as a gift to have loaded up on the cheap. I kept buying on the way down and dropped my average by over 30cents.
What is this power hour pop?
yes. lets get back to where we were before the nonsense.
20% off today. I went to order online and for some reason it wouldn't accept my zip code and kept rejecting the order. I called them and they put it through and gave me 30% off my order, without even asking. 2 thumbs up on customer service.
Not.even.a.little.
Shorts got rich this past month. Now they can cover and get rich the other way. Rinse and repeat.
Has Valens announced an exact ER date yet?
Medif announced today and they are a month behind Valens. I realize Valens already gave revenue guidance and im only expecting good things from the ER, but I personally haven't heard a solid date announced, or am I just missing it?